1-Acetylpiperazine → HCID 59553079, compound

HRID 1171417Notes

Reaction equation

Cl[CH2:2][CH2:3][O:4][C:5]1[C:14]2[C:9](=[CH:10][CH:11]=[CH:12][CH:13]=2)[C:8]([NH:15][C:16](=[O:30])[C:17]2[CH:22]=[C:21]([N:23]3[CH2:28][CH2:27][CH2:26][CH2:25][CH2:24]3)[CH:20]=[C:19]([F:29])[CH:18]=2)=[CH:7][CH:6]=1.[C:31]([N:34]1[CH2:39][CH2:38][NH:37][CH2:36][CH2:35]1)(=[O:33])[CH3:32]>>[C:31]([N:34]1[CH2:39][CH2:38][N:37]([CH2:2][CH2:3][O:4][C:5]2[C:14]3[C:9](=[CH:10][CH:11]=[CH:12][CH:13]=3)[C:8]([NH:15][C:16](=[O:30])[C:17]3[CH:22]=[C:21]([N:23]4[CH2:28][CH2:27][CH2:26][CH2:25][CH2:24]4)[CH:20]=[C:19]([F:29])[CH:18]=3)=[CH:7][CH:6]=2)[CH2:36][CH2:35]1)(=[O:33])[CH3:32]

Participants

Reactant 2

HCID 837951-Acetylpiperazine

HCID 59553352HCID 59553352, compound

Product 1

HCID 59553079HCID 59553079, compound

Procedure

Compound is prepared from N-[4-(2-chloroethoxy)-naphthalen-1-yl]-3-fluoro-5-piperidin-1-yl-benzamide and 4-acetylpiperizine according to conditions described in general procedure N. 1H NMR 300 MHz (CDCl3) 8.3 (dd, 1H, J=1.8 and 8.7 Hz), 7.9 (s, 1H), 7.84 (d, 1H, J=7.5 Hz), 7.74 (d, 1H, J=8.7 Hz), 7.54 (m, 2H), 7.31 (s, 1H), 6.99 (d, 1H, J=7.5 Hz), 6.84 (d, 1H, J=8.1Hz), 6.76 (d, 1H, J=11.7 Hz), 4.32 (t, 2H, J=5.7 Hz), 3.66 (t, 2H, J=5.4), 3.5 (t, 2H, J=5.4 Hz), 3.28 (m, 4H), 3.0 (t, 2H, J=5.7 Hz), 2.65 (m, 4H), 2.05 (s, 3H), 1.62-1.8 (m, 6H).

Sources & evidence

ORD record: ord-faa7e9015d35483baf69b90ca1dee754
Source dataset: uspto-grants-2010_11
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07829560B2

Reaction notes

Loading…